OUR TEAM

Antapodia Nanotherapeutics was co-founded by Dr. Patrick Y. Yang and Dr. Kelvin Tsai. Dr. Yang was formerly the Executive Vice President and global head of Roche Pharmaceuticals, the EVP of Technical Operations of Genentech, a Vice President of Merck and JUNO Therapeutics (acquired by Celgene) and has broad pharmaceutical industry experiences and oversees the production of Genentech’s blockbuster antibody therapeutics and JUNO’s CAR-T products. He will chair the Board of Directors and help recruit seasoned executives to the company. Dr. Tsai is a Harvard- and UCSF-trained trained cancer researcher and an experienced Gi oncologist. Dr. Tsai co-discovered the company's novel invadopodia targets and he will lead the preclinical and clinical developments of the company’s products. The company's Scientific Advisory Board includes leading experts in cancer metastasis and nanotherapy from University of Toronto, Harvard University, and Israel's Technion.

Patrick Y. Yang, Ph.D.

Patrick Y. Yang, Ph.D. (yang.pat@antapodia.com)

 

Co-founder/Chairman
Formerly EVP of Technical Operations, Genentech/Roche
EVP, Juno Therapeutics, Inc.
Board of Directors, Sanofi S.A., AstraZenica Plc., Codexis, Inc., Tesoro, Inc., PharmaEssentia Corp., Acepodia Biotech

Kelvin K. Tsai, M.D., Ph.D.

Kelvin Tsai, M.D., Ph.D. (kelvin.tsai@antapodia.com)

 

Scientific Co-founder (invadopodia, nanotherapy, cancer metastasis)
Ph.D., Harvard University, MA, USA
M.D., Taipei Medical University, Taiwan
Postdoc Fellow, University of Pennsylvania, PA, USA
Postdoc Fellow, University of California - San Francisco, CA, USA

Robert S. Kerbel, Ph.D.

Robert S. Kerbel, Ph.D. (robert.kerbel@sri.utoronto.ca)

 

Chair, Scientific Advisory Board (cancer metastasis, experimental therapeutics)
Professor, Department of Medical Biophysics, University of Toronto
Senior Scientist, Sunnybrook Research Inst., Sunnybrook Health Sciences Center, Toronto, Canada

Kevin Struhl, Ph.D.

Kevin Struhl, Ph.D. (kevin@hms.harvard.edu)

 

Scientific Advisor (cancer gene regulation)
David Wesley Gaiser Professor, Biological Chemistry and Molecular
Pharmacology
Harvard Medical School
Elected Member of National Academy of Sciences, USA
Elected Member of National Academy of Medicine, USA

Yuval Shaked, Ph.D.

Yuval Shaked, Ph.D. (yshaked@technion.ac.il)

 

Scientific Advisor (cancer metastasis; nanotherapy)
Director, Technion Integrated Cancer Center; Professor, Department of Cell
Biology and Cancer Science, Rappaport Faculty of Medicine; Technion – Israel Institute of Technology, Haifa, Israel

avi_headshot1.jpg

Avi Shroeder, Ph.D. (avids@technion.ac.il)

 

Scientific Advisor (nanotechnology, lipid nanoparticles)
Associate Professor of Chemical Engineering, Technion – Israel Institute of Technology, Haifa, Israel
President, Israel Institute of Chemical Engineering

headshot_hon-leong.jpg

Hon Leong, M.Sc., Ph.D. (hon.leong@sri.utoronto.ca)

 

Scientific Advisor (invadopodia, anti-metastasis therapy)
Associate Professor, Department of Medical Biophysics, University of Toronto
Scientist, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Canada

Copyright © Antapodia Nanotherapeutics, Inc. All Rights Reserved

Search